CVSCVS Health Corporation
AI adoption · Q1 2026 earnings call
Health CareScaling
10
extracted from this call
4 / 5
quantified with specifics
Not disclosed
no breakout in this call
CVS Health management discussed AI as a foundational and cross-enterprise capability, framing it as central to the company's evolution into a 'consumer-based health care technology company.' Key AI applications cited include prior authorization automation (95%+ approved within 24 hours, 80%+ in real time), the upcoming Health100 platform described as 'AI native,' member navigation and engagement tools, and internal productivity/efficiency improvements. Quantification of AI's financial impact was largely absent, with management declining to specify investment levels or P&L inflection timelines despite a direct analyst question.
Adopter
See full leaderboard →64/ 100
78
stage: scaling · max spec: 4
40
1 quant outcome
85
3 scopes
product_embeddedproduct_standaloneinternal_use
10 AI mentions from this call.
Extracted verbatim from the CVS Q1 2026 earnings call transcript. Speaker, section, and specificity tier surfaced for each mention.
- T4Prepared remarks· CEO· Product-embedded AI
“Our focus on embedding technology within each of our businesses has enabled us to approve more than 95% of the eligible prior authorizations within 24 hours, with over 80% being approved in real time.”
— J. Joyner, CVS earnings call - T3Q&A· Other· Internal usecan you help us understand the level and pace of AI investments you're making this year? And how we should think about the inflection point when AI shifts from net investment to net benefit on the P&L?
“For Aetna, we think about it in 3 buckets. One is in terms of investment in AI and broader technology. One is really going deliberately at cost structure and improving efficiency. And so think about this as investing in just the fundamentals of the business, accuracy, reducing rework, better forecasting, better analytics, pricing discipline. I mean, it all comes from advanced analytics and capabilities there. So that's one bucket. Second bucket, which is really important, is it's improving the way we do our work. So our colleagues can spend more time on things that matter. And that's really important to our colleagues. We need to equip our colleagues and our workforce and make sure that they're ready for this and they can really leverage it. So we just went through -- took all our leaders through an AI academy. We're launching an AI academy in a couple of weeks with all of our colleagues across Aetna, and we're going to be doing that across the enterprise.”
— Steven Nelson, CVS earnings callAI academy - T3Q&A· Other· Product-embedded AIcan you help us understand the level and pace of AI investments you're making this year?
“The third bucket, which I'm also really excited about, I mentioned earlier is investing in the capabilities and better experience, more empowerment, better insights, better navigation for our members, things like Informed Choice, our Smart Compare products, Care Pathways, they all help our members be better consumers of health care. And that's because of the leading technology we've developed in AI and our digital tools.”
— Steven Nelson, CVS earnings callInformed Choice, Smart Compare, Care Pathways - T3Prepared remarks· CEO· Standalone AI product
“Later this year, we will be launching Health100, an AI native, state-of-the-art technology and service platform that allows for any payer, PBM, pharmacy or provider to seamlessly connect.”
— J. Joyner, CVS earnings callHealth100 - T2Prepared remarks· CEO· Product-embedded AI
“But what we are most excited about and believe will have the biggest impact is AI's ability to improve consumer experiences, engagement and outcomes. It is already making it easier for our members to find the right providers and better navigate the system. We're enabling more personalized and exceptional care by empowering our pharmacists and clinicians with constantly improving insights. And we're accelerating our go-to-market strategies by using cutting-edge technology to develop deep consumer insights rapidly and at scale.”
— J. Joyner, CVS earnings call - T2Prepared remarks· CEO· Internal use
“We are focused on developing tech-forward solutions like Health100 because we believe the future of best-in-class health care companies will be powered by technology and AI. We see an immense opportunity for technology to drive systemic change across the entire health care industry. That is why we've been embedding it in everything that we do and using it to ensure that we are best-in-class in each of our businesses. AI has been deployed across CVS Health for years to improve our operations and to drive efficiencies.”
— J. Joyner, CVS earnings callHealth100 - T2Q&A· Other· Product-embedded AIcan you help us understand the level and pace of AI investments you're making this year?
“technology and AI are at the core of a lot of our businesses. And if you think about the assets that we have, we have to be industry-leading, and we have to leverage technology to operate in these businesses. And if you think about the progress we've made in PCW or the work that we're doing in HSS, they are all founded in what I'd say is industry-leading capabilities as it relates to technology and AI.”
— Prem Shah, CVS earnings call - T2Q&A· Other· Standalone AI productcan you help us understand the level and pace of AI investments you're making this year?
“as we mentioned at Investor Day, we are launching Health100, and that is really powered in the premise of our ability to engage consumers in a very different way. And we're excited about how AI is going to help us accelerate and create unique solutions for members.”
— Prem Shah, CVS earnings callHealth100 - T2Q&A· Other· Product-embedded AIhow you're actually seen so far that you discussed in the slides, and then whether to think those are kind of across the board or more notable in certain businesses?
“we've also been focused on returning Aetna to leading capabilities. We've been moving from a transaction kind of orientation to a consumer solutions orientation. So we've been investing in technology, AI, and have been driving some really nice results there.”
— Steven Nelson, CVS earnings call - T1Q&A· CEO· Internal usecan you help us understand the level and pace of AI investments you're making this year? And how we should think about the inflection point when AI shifts from net investment to net benefit on the P&L?
“I've talked with our own team about the fact that we're moving from a consumer-based health care company to a consumer-based health care technology company. And we think we're really at the center of being able to leverage technology to engage the consumer.”
— J. Joyner, CVS earnings call
What management wouldn’t quantify.
Analyst questions where management declined to share a specific number. The pattern of refusals is often as informative as the disclosures.
- Analyst Andrew Mok (Barclays) directly asked about the level and pace of AI investments in 2026 and the inflection point when AI shifts from net investment to net benefit on the P&L. Management did not provide any dollar figures for AI investment, capex, or opex, nor did they specify a timeline for P&L inflection. Response was qualitative and strategic only.
- No AI revenue attribution or ARR figures were disclosed for any AI product or initiative.
- No quantification of productivity savings, headcount impact, or cost reduction attributable to AI was provided.
- Health100 launch timing described as 'later this year' with no specific quarter, revenue model, or adoption targets disclosed.
- AI academy rollout mentioned for Aetna colleagues but no scale (headcount, timeline, investment) provided.
Compare with peers.
Other companies in the same sector and at the same AI adoption stage.
Same GICS sector, all stages
Independent research, direct to your inbox.
Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.